Other Targets

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC22671	Saredutant	A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor.
DC22970	BMS 843496	A potent and selective PDE10A inhibitor with binding affinity (Kd) of 0.15 nM, IC50 of 2.11 nM.
DC22968	TC-E 5005	A potent and selective PDE10A inhibitor with IC50 of 7.28 nM.
DC26074	CD 1530	A potent and selective RARγ receptor agonist with Ki of 150 nM.
DC22341	H-1152	A potent and selective ROCK inhibitor with Ki of 1.6 nM.
DC22655	UNC-1679 Featured	UNC-1679 (UNC1679) is a potent and selective small molecule chemical probe of a methyl-lysine reader protein L3MBTL3 with Ki of 0.35 uM.
DC24175	A-770041	A potent and selective small-molecule inhibitor of Lck with IC50 of 147 nM.
DC21581	RO 5203648 Featured	A potent and selective TAAR1 partial agonist with Ki of 0.5, 1.0, 6.8 and 2.6 nM for mouse, rat, human and monkey TAAR1, respectively.
DC22715	RP-67580	A potent and selective tachykinin NK1 receptor antagonist with Ki of 2.9 nM.
DC23840	IN-1233	A potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 34 nM, prevents tissue hyperplasia in the rat urethra or common iliac artery..
DC23839	IN-1233 phosphate	A potent and selective TGF-βRI (ALK5) inhibitor with IC50 of 34 nM, prevents tissue hyperplasia in the rat urethra or common iliac artery..
DC22380	NNC 55-0396 2HCl Featured	NNC 55-0396, Mibefradil derivative, is a highly selective T-type calcium channel blocker; displays IC50 values of 6.8 and > 100 μM for inhibition of Cav3.1 T-type channels and HVA currents respectively in INS-1 cells. IC50 value: 6.8 nMTarget: Cav3.1 T-type channelNNC 55-0396 can be an essential tool in preventing human ovarian cancer cell proliferation as a result of its ability to inhibit the function of T-type Ca2+ channels. It is believed that NNC 55-0396 may functions by dissolving in or passing through the plasma membrane of cells.
DC22534	PI4KIIIbeta-IN-10 Featured	A potent and selective type III phosphatidylinositol 4-kinase (PI4KIIIβ) inhibitor with IC50 of 3.6 nM.
DC23086	Vandetanib hydrochloride	A potent and selective VEGFR2 (KDR) inhibitor with IC50 of 40 nM.
DC25087	Vandetanib trifluoroacetate	A potent and selective VEGFR2 (KDR) inhibitor with IC50 of 40 nM.
DC20627	ABT 089 dihydrochloride	A potent and selective α4β2 nAChR agonist with Ki of 16 nM.
DC22885	TAN-67 dihydrobromide	A potent and selective δ-opioid receptor agonist that has high affinity and selectivity for the δ1 subtype with Ki of 1.12 nM.
DC23520	VU 6001966	A potent and selective, CNS penetrant mGlu2 negative allosteric modulator with IC50 of 78 nM.
DC23521	VU 6010572	A potent and selective, CNS penetrant mGlu3 negative allosteric modulator with IC50 of 245 nM.
DC22979	PF-04822163	A potent and selective, CNS-penetrant PDE1 inhibitor with IC50 of 2.4 nM for PDE1B..
DC22978	PF-04471141 hydrochloride	A potent and selective, CNS-penetrant PDE1 inhibitor with IC50 of 35 nM for PDE1B..
DC22802	MK2-IN-28	A potent and selective, non-ATP competitive, allosteric MAPKAPK2/3 (MK2/3) inhibitor with IC50 of 8 nM for MK2, hTNFα EC50 of 0.31 uM.
DC20888	Fadrozole	A potent and selective, orally bioavailable aromatase inhibitor with IC50 of 1.7 nM, 180 times more potent than aminoglutethimide.
DC21004	EXEL-8232	A potent and selective, orally bioavailable JAK2 inhibitor with IC50 of 2 nM.
DC23843	BMS-935177	A potent and selective, orally bioavailable, reversible BTK inhibitor with IC50 of 2.8 nM.
DC22913	WEB-2086 Featured	A potent and specific antagonist of platelet activating factor (PAF) receptor that inhibits PAF-induced human platelet and neutrophil aggregation in vitro with IC50 of 0.17 and 0.36 uM, respectively.
DC23392	RX-37	A potent and specific BET bromodomain inhibitor with Ki of 3.2-24.7 nM for BD1 and BD2 domains of BRD2, BRD3, and BRD4.
DC22375	RS-102895 Featured	RS102895 is a potent CCR2 antagonist, with an IC50 of 360 nM, and shows no effect on CCR1.
DC22432	CCX2553	A potent and specific CCR6 antagonist.
DC24199	OSU-T315 (ILK-IN-1) Featured	OSU-T315 (ILK-IN-1) is a potent and specific integrin-linked kinase (ILK) inhibitor which inhibits PDK2 function in the AKT pathway activation

Other Targets

Customized Consultation X

Your information is safe with us. * Required Fields.